Edition:
United States

Prophase Labs Inc (PRPH.OQ)

PRPH.OQ on NASDAQ Stock Exchange Capital Market

1.89USD
26 May 2017
Change (% chg)

$0.02 (+1.07%)
Prev Close
$1.87
Open
$1.89
Day's High
$1.90
Day's Low
$1.89
Volume
252
Avg. Vol
3,062
52-wk High
$2.37
52-wk Low
$1.28

PRPH.OQ

Chart for PRPH.OQ

About

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK... (more)
No analyst recommendations are available for PRPH.OQ.

Overall

Beta: 0.09
Market Cap(Mil.): $32.43
Shares Outstanding(Mil.): 17.16
Dividend: --
Yield (%): --

Financials

  PRPH.OQ Industry Sector
P/E (TTM): 2.19 22.65 41.14
EPS (TTM): 0.86 -- --
ROI: 51.62 12.57 53.14
ROE: 52.93 15.80 60.83

BRIEF-ProPhase provides shareholder update

* ProPhase Labs Inc- Company received net proceeds from sale of cold-eeze(®) of approximately $39.3 million after certain deductions

Apr 05 2017

BRIEF-Prophase labs announces agreement to sell cold-eeze(r) brand

* Prophase labs announces agreement to sell cold-eeze(r) brand

Jan 09 2017

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.